Pharmaceutical Data Services
Prescription audit firm will be purchased by Stamford, Connecticut-based drug sales management firm Walsh International for an undisclosed amount. PDS is a subsidiary of third-party prescription drug claims processing operation PCS, which is 86% owned by drug wholesaler McKesson. Walsh is also entering into long-term agreements to purchase data from PCS and McKesson Corp. PDS will remain based in Scottsdale, Arizona.
You may also be interested in...
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Alvotech has struck a major deal with Yangtze River Pharmaceutical that will allow eight of the biosimilars developer’s products to be commercialized in China.